Systamex Vet. 3,75 g intraruminalinnlegg, periodevis frisetting
Systamex Vet. 3,75 g intraruminalinnlegg, periodevis frisetting
Authorised
- Oxfendazole
Product identification
Medicine name:
Systamex Vet. 3,75 g intraruminalinnlegg, periodevis frisetting
Active substance:
- Oxfendazole
Target species:
-
Cattle
Route of administration:
-
Intraruminal use
Product details
Active substance and strength:
-
Oxfendazole3.75/gram(s)5.00Tablet
Pharmaceutical form:
-
Continuous-release intraruminal device
Withdrawal period by route of administration:
-
Intraruminal use
-
Cattle
-
Meat and offal180dayIkke godkjent til melkekyr som leverer melk til konsum, samt dyr som har mindre enn 6 måneder til kalving, såfremt melken fra disse skal leveres til konsum. Ved slakting t.o.m. dag 14 etter inngift er virkestoff ennå ikke utløst og slaktet kan godkjennes.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Norway
Available in:
-
Norway
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Zoetis Animal Health ApS
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- Norwegian Medical Products Agency
Authorisation number:
- 0000-07727
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Norwegian (PDF)
Published on: 19/09/2023
Updated on: 21/09/2023
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Norwegian (PDF)
Published on: 19/09/2023
Updated on: 21/09/2023
